Molecular mechanism of the short-term cardiotoxicity caused by 2 ',3 '-dideoxycytidine (ddC): Modulation of reactive oxygen species levels and ADP-ribosylation reactions
G. Skuta et al., Molecular mechanism of the short-term cardiotoxicity caused by 2 ',3 '-dideoxycytidine (ddC): Modulation of reactive oxygen species levels and ADP-ribosylation reactions, BIOCH PHARM, 58(12), 1999, pp. 1915-1925
The short-term cardiac side effects of 2',3'-dideoxycytidine (ddC, zalcitab
ine) were studied in rats in order to understand the biochemical events con
tributing to the development of ddC-induced cardiomyopathy. In developing a
nimals, ddC treatment provoked a surprisingly rapid appearance of cardiac m
alfunctions characterized by prolonged RR, PR, and QT intervals and J point
depression. The energy metabolism in the heart was compromised, characteri
zed by a decreased creatine phosphate/creatine ratio (from 2.05 normal valu
e to 0.75) and a decreased free ATP/ADP ratio (from 332 normal value to 121
). The activity of respiratory complexes (NADH: cytochrome c oxidoreductase
and cytochrome oxidase) also decreased significantly. Southern blot and po
lymerase chain reaction analysis did not show deletions or a decrease in th
e quantity of mitochondrial DNA (mtDNA) deriving from ddC-treated rat heart
s, indicating that under our experimental conditions, ddC-induced heart abn
ormalities were not the direct consequence of mtDNA-related damage. The ddC
treatment of rats significantly increased the formation of reactive oxygen
species (ROS) in heart and skeletal muscle as determined by the oxidation
of non-fluorescent dihydrorhodamine123 to fluorescent rhodamine123 and the
oxidation of cellular proteins determined from protein carbonyl content. An
activation of the nuclear poly-(ADP-ribose) polymerase (EC 2.4.2.30) and a
n increase in the mono-ADP-ribosylation of glucose-regulated protein and de
smin were observed in the cardiac tissue from ddC-treated animals. A decrea
se in the quantity of heat shock protein (HSP)70s was also detected, while
the level of HSP25 and HSP60 remained unchanged. Surprisingly, ddC treatmen
t induced a skeletal muscle-specific decrease in the quantity of three prot
eins, one of which was identified by N-terminal sequencing as myoglobin, an
d another by tandem mass spectrometer sequencing as triosephosphate isomera
se (EC 5.3.1.1). These data show that the short term cardiotoxicity of ddC
is partially based on ROS-mediated signalling through poly- and mono-ADP-ri
bosylation reactions and depression of HSP70 levels, whose processes repres
ent a new mtDNA independent mechanism for ddC-induced cell damage. (C) 1999
Elsevier Science Inc.